Overexpression of PRL in patients with diabetic retinopathy results in accumulation of vasoinhibins in the retina, inhibition of vascular endothelial growth factor (VEGF), inactivation of nitric oxide synthase (NOS), and prevention of retinal vasopermeability [23,25,26,27,28,29]. Here, VEGFA is linked to diabetic retinopathy.